NCT04999566 is a clinical trial in Metabolism, Inborn Errors, sponsored by University of Lausanne.

Who is sponsoring NCT04999566?

NCT04999566 is sponsored by University of Lausanne.

What condition does NCT04999566 study?

NCT04999566 studies Metabolism, Inborn Errors.

Is NCT04999566 still recruiting?

NCT04999566 is currently completed. Last updated 4 December 2024.

Last reviewed 2024-12-04 · How we verify

NCT04999566

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Manifestation and Inherited Metabolic Diseases

Completed Last updated 4 December 2024

What this trial tests

trial in Metabolism, Inborn Errors in 30 participants. Completed in 2 September 2024.

Timeline

1 May 2021

Primary endpoint
30 January 2023

2 September 2024

Quick facts

Lead sponsor	University of Lausanne
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 May 2021
Primary completion	30 January 2023
Estimated completion	2 September 2024
Sites	1 location across Switzerland

Conditions studied

Metabolism, Inborn Errors — all drugs for Metabolism, Inborn Errors →

Sponsor

University of Lausanne

Who can join

16 and older, any sex, with Metabolism, Inborn Errors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to report and describe cardiac manifestations associated with IMD in a cohort of patients followed in a reference center for rare diseases (Lausanne University Hospital, CHUV) from 2017-2020.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cardiac manifestations in adult patients with inherited metabolic disease: A single-center experience.
Sadiku F, Rutz T, Superti-Furga A, Monney P, et al · · 2025 · cited 1× · PMID 40276563 · DOI 10.1016/j.ymgmr.2025.101216

Verify or expand the search:

Other University of Lausanne trials

Trials by the same sponsor.

NCT06464432 — Complex-Posttraumatic Stress Disorder in Urban Egypt: Pilot Testing of a Culturally-adapted Evidence-Based Treatment Man · NA · recruiting
NCT06123546 — Effectiveness of a Patient-oriented Discharge Summary · NA · completed
NCT06121128 — The Effects of Inspiratory Muscle Training on Endurance Performance in Trained Athletes Under Normoxic and Hypoxic Condi · NA · unknown
NCT05908214 — The Application of Wide Pulse High Frequency Neuromuscular Electrical Stimulation in Disorders Associated With Motoneuro · NA · recruiting
NCT05818566 — Orphan Drugs for Inherited Metabolic Diseases · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04999566 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Lausanne
Last refreshed: 4 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04999566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing